HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $27,401 | -99.2% | 18,138 | -95.4% | 0.00% | -100.0% |
Q4 2021 | $3,599,000 | +3.3% | 394,473 | +21.0% | 0.01% | 0.0% |
Q3 2021 | $3,485,000 | -36.5% | 325,950 | -7.1% | 0.01% | -41.7% |
Q2 2021 | $5,489,000 | +24.0% | 351,011 | +28.6% | 0.01% | +9.1% |
Q1 2021 | $4,425,000 | -49.6% | 272,958 | -34.3% | 0.01% | -52.2% |
Q4 2020 | $8,788,000 | +27.7% | 415,216 | -10.6% | 0.02% | +15.0% |
Q3 2020 | $6,880,000 | +269.7% | 464,238 | +266.9% | 0.02% | +233.3% |
Q2 2020 | $1,861,000 | +24.1% | 126,517 | -0.9% | 0.01% | 0.0% |
Q1 2020 | $1,499,000 | +89.5% | 127,701 | +291.9% | 0.01% | +200.0% |
Q4 2019 | $791,000 | +34.1% | 32,581 | -1.5% | 0.00% | 0.0% |
Q3 2019 | $590,000 | -48.7% | 33,085 | +11.9% | 0.00% | -50.0% |
Q2 2018 | $1,149,000 | +3279.4% | 29,560 | +1185.8% | 0.00% | – |
Q1 2017 | $34,000 | +21.4% | 2,299 | +8.9% | 0.00% | – |
Q4 2016 | $28,000 | -22.2% | 2,111 | +0.3% | 0.00% | – |
Q3 2016 | $36,000 | -87.1% | 2,105 | -81.7% | 0.00% | -100.0% |
Q3 2015 | $280,000 | – | 11,483 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |